2023-11-06
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Ant
BioNTech will hold exclusive licenses to develop and commercialize PM8002 globally excluding Greater China
2023-10-12
MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTec
MediLink announced that it has entered into a strategic research collaboration and worldwide license agreement with BioNTech SE
2023-06-12
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
Viva successfully raised nearly US$ 150 million through the transfer of approximately 24% of its equity interest to Temasek, HLC, and True Light.
2023-05-20
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS
Etana has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Venture.
2022-09-16
China's HighLight hits first close onlife sciences fund, targets $650m
HighLight Capital, a China-based life sciences investor, has completeda first close of USD 540m on its fourth US dollar-denominated fund.
2021-07-21